# GO_molecular_function_0069

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_molecular_function`  
**Author expected answer:** **B** — FMN binding

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MDNSSRLFSPLRLGKCQLRHRVAMSPLTRFRADDLSVQMPFAKEYYAQRASVPGTFLVSEATSISRESVGFSNVPGIWNAEQVRAWKEIADDVHCKGSFLFLQLWATGRSATPERLQSGDFDFASSSAVPMEPGGAVPRELTEEDIHDLIARFAEAARRAIDAGMDGIELHAANGYLIDQFTQASCNQRTDRWGGSIENRARFAIEVTRSVVAAVGADRVGVKLSPWGKIQGMGTMQDLVPQFQYLVSELRDMGLAYLRLSNSRWIDGVPQEEEDNSIYVHTWGASRPVLLEGGYDPISAQKEADIRFNGYDAVIAFGRFFISNPDLPFRIKAGVDLQKYNRDTFYTPISEKGYIDYPFSTAFLEEHSSKASLKL

[Multiple Choices]
A. peptide binding
B. FMN binding
C. amidophosphoribosyltransferase activity
D. flavin adenine dinucleotide binding
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the FrzD entry, whose historical and current UniProt annotations include FMN binding. That GO annotation is computationally assigned by InterPro (IEA), not direct experimental evidence of FMN binding; separate cited evidence supports FrzD's flavin-dependent reductase role.

Citations as saved: [C1](#evidence-c1), [C7](#evidence-c7), [H5](#evidence-h5), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The options make flavin-cofactor binding a relevant distinction, but the sequence alone provides no sufficiently concrete cue here to choose FMN over FAD binding.


**Missing item-specific fact**

> The protein's identification as FrzD, or an equivalent family/cofactor annotation establishing FMN rather than FAD specificity, is absent from the input.


**Reason**

> The expected choice is supported by sequence-matched database evidence, but that protein-specific annotation was not supplied. Recognizing the exact sequence or recalling its entry would be lookup or memorization, not reasoning from the presented information.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The listed functions are distinct; the issue is that the input does not provide a reliable basis to resolve the FMN-versus-FAD distinction, rather than the wording making multiple functions simultaneously correct.


### Important caveats

- The FMN-binding GO annotation is IEA:InterPro and should not be represented as a direct experimental binding measurement.
- The exact author annotation snapshot is unknown, although a historical sequence-matched entry already contains the FMN-binding annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The options make flavin-cofactor binding a relevant distinction, but the sequence alone provides no sufficiently concrete cue here to choose FMN over FAD binding.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's identification as FrzD, or an equivalent family/cofactor annotation establishing FMN rather than FAD specificity, is absent from the input.",
    "reason": "The expected choice is supported by sequence-matched database evidence, but that protein-specific annotation was not supplied. Recognizing the exact sequence or recalling its entry would be lookup or memorization, not reasoning from the presented information."
  },
  "case_id": "GO_molecular_function_0069",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C7",
      "H5",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the FrzD entry, whose historical and current UniProt annotations include FMN binding. That GO annotation is computationally assigned by InterPro (IEA), not direct experimental evidence of FMN binding; separate cited evidence supports FrzD's flavin-dependent reductase role."
  },
  "important_caveats": [
    "The FMN-binding GO annotation is IEA:InterPro and should not be represented as a direct experimental binding measurement.",
    "The exact author annotation snapshot is unknown, although a historical sequence-matched entry already contains the FMN-binding annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The listed functions are distinct; the issue is that the input does not provide a reliable basis to resolve the FMN-versus-FAD distinction, rather than the wording making multiple functions simultaneously correct."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0069",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the FrzD entry, whose historical and current UniProt annotations include FMN binding. That GO annotation is computationally assigned by InterPro (IEA), not direct experimental evidence of FMN binding; separate cited evidence supports FrzD's flavin-dependent reductase role.",
    "evidence_ids": ["C1", "C7", "H5", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The options make flavin-cofactor binding a relevant distinction, but the sequence alone provides no sufficiently concrete cue here to choose FMN over FAD binding.",
    "missing_item_specific_fact": "The protein's identification as FrzD, or an equivalent family/cofactor annotation establishing FMN rather than FAD specificity, is absent from the input.",
    "reason": "The expected choice is supported by sequence-matched database evidence, but that protein-specific annotation was not supplied. Recognizing the exact sequence or recalling its entry would be lookup or memorization, not reasoning from the presented information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The listed functions are distinct; the issue is that the input does not provide a reliable basis to resolve the FMN-versus-FAD distinction, rather than the wording making multiple functions simultaneously correct."
  },
  "important_caveats": [
    "The FMN-binding GO annotation is IEA:InterPro and should not be represented as a direct experimental binding measurement.",
    "The exact author annotation snapshot is unknown, although a historical sequence-matched entry already contains the FMN-binding annotation."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A7T8F1M9 (FrzD, a flavin-dependent old-yellow enzyme/OYE from Cladobotryum sp.) carries GO:0010181 (FMN binding) with IEA:InterPro evidence (C7, H5). The protein is explicitly named 'Flavin-dependent old-yellow enzyme FrzD' and described as a 'flavin-dependent reductase' with experimental evidence (ECO:0000269|PubMed:33372776) (C4, C5, H1, H3). OYE enzymes are a well-characterized FMN-dependent family. The catalytic reaction uses NADPH (C6, H4), consistent with FMN-dependent reductase activity. No FAD-binding annotation is present. The FMN binding assignment is consistent with both the computational (InterPro) and the experimental context of the entry.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H1](#evidence-h1), [H3](#evidence-h3), [H4](#evidence-h4), [H5](#evidence-h5), [GO2](#evidence-go2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could reason from the sequence that the protein is a flavoprotein oxidoreductase (length ~375 aa, presence of flavoprotein-like motifs such as 'GADRVGVKLSPWGKIQGMGTMQDLVPQFQYLVSELRDMGLAYLRLSNSRWIDGVPQ', NADPH-utilizing reductase context). This would eliminate options A (peptide binding) and C (amidophosphoribosyltransferase activity). However, the critical distinction between B (FMN binding) and D (FAD binding) requires knowing that this protein belongs to the Old Yellow Enzyme (OYE) family, which is specifically FMN-dependent. The raw sequence does not contain a simple, universally recognizable motif that unambiguously distinguishes FMN from FAD binding without family-level assignment.


**Missing item-specific fact**

> The specific family assignment of this protein as an OYE (Old Yellow Enzyme) family member, which carries the well-known general-knowledge implication that OYE enzymes use FMN rather than FAD. Without recognizing the protein as OYE, the sequence provides grounds to call it a flavoprotein but not to specify FMN over FAD.


**Reason**

> Eliminating A and C is feasible by general reasoning (no peptide-binding domain architecture, no amidotransferase fold). However, distinguishing B from D requires identifying the protein as an OYE-family enzyme, which is a family/database assignment rather than a straightforward sequence-motif inference. The FMN-vs-FAD distinction is family-specific and not derivable from generic flavoprotein sequence features alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "D"
]
```

> Both B (FMN binding) and D (FAD binding) describe flavin cofactor binding. For a protein identified only as a 'flavoprotein oxidoreductase' from sequence, both are plausible without family-level knowledge. The UniProt entry annotates only FMN binding (GO:0010181) and not FAD binding, and the OYE family is FMN-specific, but this distinction is not obvious from the raw sequence alone. Options A and C are clearly eliminable.


### Important caveats

- The FMN binding annotation carries evidence code IEA:InterPro (computational inference from domain match), not direct experimental binding measurement. However, the protein is experimentally characterized as a 'flavin-dependent' reductase (ECO:0000269), and OYE flavin dependence is well-established in the literature.
- The UniProt entry was first publicly released in June 2025; the benchmark construction date is unknown, so the annotation may or may not have been available when the question was authored.
- The GO term for FMN binding (GO:0010181) is annotated via InterPro, a computational transfer method, while the protein's function and catalytic activity are supported by experimental evidence (PubMed:33372776).
- The sequence-match is confirmed (SHA-256 identical between benchmark and UniProt entry), so the annotation applies to the exact sequence presented.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could reason from the sequence that the protein is a flavoprotein oxidoreductase (length ~375 aa, presence of flavoprotein-like motifs such as 'GADRVGVKLSPWGKIQGMGTMQDLVPQFQYLVSELRDMGLAYLRLSNSRWIDGVPQ', NADPH-utilizing reductase context). This would eliminate options A (peptide binding) and C (amidophosphoribosyltransferase activity). However, the critical distinction between B (FMN binding) and D (FAD binding) requires knowing that this protein belongs to the Old Yellow Enzyme (OYE) family, which is specifically FMN-dependent. The raw sequence does not contain a simple, universally recognizable motif that unambiguously distinguishes FMN from FAD binding without family-level assignment.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific family assignment of this protein as an OYE (Old Yellow Enzyme) family member, which carries the well-known general-knowledge implication that OYE enzymes use FMN rather than FAD. Without recognizing the protein as OYE, the sequence provides grounds to call it a flavoprotein but not to specify FMN over FAD.",
    "reason": "Eliminating A and C is feasible by general reasoning (no peptide-binding domain architecture, no amidotransferase fold). However, distinguishing B from D requires identifying the protein as an OYE-family enzyme, which is a family/database assignment rather than a straightforward sequence-motif inference. The FMN-vs-FAD distinction is family-specific and not derivable from generic flavoprotein sequence features alone."
  },
  "case_id": "GO_molecular_function_0069",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "C7",
      "H1",
      "H3",
      "H4",
      "H5",
      "GO2"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8F1M9 (FrzD, a flavin-dependent old-yellow enzyme/OYE from Cladobotryum sp.) carries GO:0010181 (FMN binding) with IEA:InterPro evidence (C7, H5). The protein is explicitly named 'Flavin-dependent old-yellow enzyme FrzD' and described as a 'flavin-dependent reductase' with experimental evidence (ECO:0000269|PubMed:33372776) (C4, C5, H1, H3). OYE enzymes are a well-characterized FMN-dependent family. The catalytic reaction uses NADPH (C6, H4), consistent with FMN-dependent reductase activity. No FAD-binding annotation is present. The FMN binding assignment is consistent with both the computational (InterPro) and the experimental context of the entry."
  },
  "important_caveats": [
    "The FMN binding annotation carries evidence code IEA:InterPro (computational inference from domain match), not direct experimental binding measurement. However, the protein is experimentally characterized as a 'flavin-dependent' reductase (ECO:0000269), and OYE flavin dependence is well-established in the literature.",
    "The UniProt entry was first publicly released in June 2025; the benchmark construction date is unknown, so the annotation may or may not have been available when the question was authored.",
    "The GO term for FMN binding (GO:0010181) is annotated via InterPro, a computational transfer method, while the protein's function and catalytic activity are supported by experimental evidence (PubMed:33372776).",
    "The sequence-match is confirmed (SHA-256 identical between benchmark and UniProt entry), so the annotation applies to the exact sequence presented."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "D"
    ],
    "reason": "Both B (FMN binding) and D (FAD binding) describe flavin cofactor binding. For a protein identified only as a 'flavoprotein oxidoreductase' from sequence, both are plausible without family-level knowledge. The UniProt entry annotates only FMN binding (GO:0010181) and not FAD binding, and the OYE family is FMN-specific, but this distinction is not obvious from the raw sequence alone. Options A and C are clearly eliminable."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0069",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8F1M9 (FrzD, a flavin-dependent old-yellow enzyme/OYE from Cladobotryum sp.) carries GO:0010181 (FMN binding) with IEA:InterPro evidence (C7, H5). The protein is explicitly named 'Flavin-dependent old-yellow enzyme FrzD' and described as a 'flavin-dependent reductase' with experimental evidence (ECO:0000269|PubMed:33372776) (C4, C5, H1, H3). OYE enzymes are a well-characterized FMN-dependent family. The catalytic reaction uses NADPH (C6, H4), consistent with FMN-dependent reductase activity. No FAD-binding annotation is present. The FMN binding assignment is consistent with both the computational (InterPro) and the experimental context of the entry.",
    "evidence_ids": ["C4", "C5", "C6", "C7", "H1", "H3", "H4", "H5", "GO2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could reason from the sequence that the protein is a flavoprotein oxidoreductase (length ~375 aa, presence of flavoprotein-like motifs such as 'GADRVGVKLSPWGKIQGMGTMQDLVPQFQYLVSELRDMGLAYLRLSNSRWIDGVPQ', NADPH-utilizing reductase context). This would eliminate options A (peptide binding) and C (amidophosphoribosyltransferase activity). However, the critical distinction between B (FMN binding) and D (FAD binding) requires knowing that this protein belongs to the Old Yellow Enzyme (OYE) family, which is specifically FMN-dependent. The raw sequence does not contain a simple, universally recognizable motif that unambiguously distinguishes FMN from FAD binding without family-level assignment.",
    "missing_item_specific_fact": "The specific family assignment of this protein as an OYE (Old Yellow Enzyme) family member, which carries the well-known general-knowledge implication that OYE enzymes use FMN rather than FAD. Without recognizing the protein as OYE, the sequence provides grounds to call it a flavoprotein but not to specify FMN over FAD.",
    "reason": "Eliminating A and C is feasible by general reasoning (no peptide-binding domain architecture, no amidotransferase fold). However, distinguishing B from D requires identifying the protein as an OYE-family enzyme, which is a family/database assignment rather than a straightforward sequence-motif inference. The FMN-vs-FAD distinction is family-specific and not derivable from generic flavoprotein sequence features alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "D"],
    "reason": "Both B (FMN binding) and D (FAD binding) describe flavin cofactor binding. For a protein identified only as a 'flavoprotein oxidoreductase' from sequence, both are plausible without family-level knowledge. The UniProt entry annotates only FMN binding (GO:0010181) and not FAD binding, and the OYE family is FMN-specific, but this distinction is not obvious from the raw sequence alone. Options A and C are clearly eliminable."
  },
  "important_caveats": [
    "The FMN binding annotation carries evidence code IEA:InterPro (computational inference from domain match), not direct experimental binding measurement. However, the protein is experimentally characterized as a 'flavin-dependent' reductase (ECO:0000269), and OYE flavin dependence is well-established in the literature.",
    "The UniProt entry was first publicly released in June 2025; the benchmark construction date is unknown, so the annotation may or may not have been available when the question was authored.",
    "The GO term for FMN binding (GO:0010181) is annotated via InterPro, a computational transfer method, while the protein's function and catalytic activity are supported by experimental evidence (PubMed:33372776).",
    "The sequence-match is confirmed (SHA-256 identical between benchmark and UniProt entry), so the annotation applies to the exact sequence presented."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8F1M9` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 11. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M9.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.159757+00:00.  

```json
"A0A7T8F1M9"
```

Source SHA-256: `c38628844912ac2c4aa489f4067b5327e7aad3e6384ffb308551b50b6f0b30ee`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M9.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.159757+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis cluster protein D"}},{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"Flavin-dependent old-yellow enzyme FrzD"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"Flavin-dependent OYE"}]}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"1.3.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"Aldehyde reductase FrzD"}}}
```

Source SHA-256: `c38628844912ac2c4aa489f4067b5327e7aad3e6384ffb308551b50b6f0b30ee`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M9.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.159757+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"Aldehyde reductase; part of the gene cluster that mediates the biosynthesis of the alkaloid (-)-FR901483, a potent immunosuppressant that shows efficacy in animal models and a probable inhibitor of purine nucleotide biosynthesis by targeting phosphoribosylpyrophosphate amidotransferase (PPAT) (PubMed:33372776). Within the pathway, FrzD reduces the dienone portion of the pathway intermediates to cyclohexanone (PubMed:33372776). The biosynthesis of (-)-FR901483 starts with the condensation of two L-tyrosines to yield (S,S)-dityrosyl-piperazine. This process occurs in 3 steps with the non-canonical nonribosomal peptide synthetase FrzA catalyzing the reduction of L-tyrosine into L-tyrosinal, the spontaneous condensation of 2 L-tyrosinal units, and the subsequent reduction by the NmrA-like family domain-containing oxidoreductase FrzB. The cytochrome P450 monooxygenase FrzC then performs coupling between N10 and C1' to morph the piperazine into a 1,4-diazabicyclo[3.2.1]octane spiro-fused to a 2,5-cyclohexadienone. The dienone portion is further reduced to cyclohexanone by the flavin-dependent reductase FrzD. The methyltranserases (MTs) FrzE and FrzF are then involved in the methylation at the C10' amine and the C4 phenolic oxygen, respectively. The order of the two MTs appear to be interchangeable. Cleavage of the C9-N10' bond by the dioxygenase FrzG then leads to formation of a conjugated iminium. In addition to the oxidation of C9, an additional dehydrogenation between C7 and C8 can occur to give a likely shunt product. The next biosynthetic step is the intramolecular aldol condensation catalyzed by the newly identified aldolase FrzH to yield an aza-tricyclic product with the formation of a C9-C3' bond (PubMed:33372776). The short-chain dehydrogenase/reductase FrzI then produces dephospho-(-)-FR901483 that is phosphorylated at C4'-OH into (-)-FR901483 by the phosphotransferase FrzJ (PubMed:33372776). The only unassigned enzyme in the cluster is the second cytochrome P450 monooxygenase FrzL (PubMed:33372776)"}]}
```

Source SHA-256: `c38628844912ac2c4aa489f4067b5327e7aad3e6384ffb308551b50b6f0b30ee`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M9.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.159757+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","physiologicalReactions":[{"directionType":"left-to-right","evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"reactionCrossReference":{"database":"Rhea","id":"RHEA:83584"}}],"reaction":{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"name":"(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexane]-2',5'-dien-4'-one + 2 NADPH + 2 H(+) = (1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + 2 NADP(+)","reactionCrossReferences":[{"database":"Rhea","id":"RHEA:83583"},{"database":"ChEBI","id":"CHEBI:15378"},{"database":"ChEBI","id":"CHEBI:57783"},{"database":"ChEBI","id":"CHEBI:58349"},{"database":"ChEBI","id":"CHEBI:233174"},{"database":"ChEBI","id":"CHEBI:233175"}]}}
```

Source SHA-256: `c38628844912ac2c4aa489f4067b5327e7aad3e6384ffb308551b50b6f0b30ee`.

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M9.json)  
**Locator:** `/uniProtKBCrossReferences/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.159757+00:00.  

```json
{"database":"GO","id":"GO:0010181","properties":[{"key":"GoTerm","value":"F:FMN binding"},{"key":"GoEvidenceType","value":"IEA:InterPro"}]}
```

Source SHA-256: `c38628844912ac2c4aa489f4067b5327e7aad3e6384ffb308551b50b6f0b30ee`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M9?format=txt&versions=11)  
**Locator:** `lines 1-15`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-01T06:27:35.126419+00:00.  

```text
ID   FRZD_CLASX              Reviewed;         375 AA.
AC   A0A7T8F1M9;
DT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.
DT   02-JUN-2021, sequence version 1.
DT   18-JUN-2025, entry version 11.
DE   RecName: Full=Aldehyde reductase FrzD {ECO:0000303|PubMed:33372776};
DE            EC=1.3.1.- {ECO:0000269|PubMed:33372776};
DE   AltName: Full=FR901483 biosynthesis cluster protein D {ECO:0000303|PubMed:33372776};
DE   AltName: Full=Flavin-dependent old-yellow enzyme FrzD {ECO:0000303|PubMed:33372776};
DE            Short=Flavin-dependent OYE {ECO:0000303|PubMed:33372776};
GN   Name=FrzD {ECO:0000303|PubMed:33372776};
OS   Cladobotryum sp.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Cladobotryum.
OX   NCBI_TaxID=2040732;
```

Source SHA-256: `fd48d108f45a92963462c2f0a750dcecfac5cc36c43941b4ca5d31b971333839`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M9?format=txt&versions=11)  
**Locator:** `lines 25-55`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-01T06:27:35.126419+00:00.  

```text
CC   -!- FUNCTION: Aldehyde reductase; part of the gene cluster that mediates
CC       the biosynthesis of the alkaloid (-)-FR901483, a potent
CC       immunosuppressant that shows efficacy in animal models and a probable
CC       inhibitor of purine nucleotide biosynthesis by targeting
CC       phosphoribosylpyrophosphate amidotransferase (PPAT) (PubMed:33372776).
CC       Within the pathway, FrzD reduces the dienone portion of the pathway
CC       intermediates to cyclohexanone (PubMed:33372776). The biosynthesis of
CC       (-)-FR901483 starts with the condensation of two L-tyrosines to yield
CC       (S,S)-dityrosyl-piperazine. This process occurs in 3 steps with the
CC       non-canonical nonribosomal peptide synthetase FrzA catalyzing the
CC       reduction of L-tyrosine into L-tyrosinal, the spontaneous condensation
CC       of 2 L-tyrosinal units, and the subsequent reduction by the NmrA-like
CC       family domain-containing oxidoreductase FrzB. The cytochrome P450
CC       monooxygenase FrzC then performs coupling between N10 and C1' to morph
CC       the piperazine into a 1,4-diazabicyclo[3.2.1]octane spiro-fused to a
CC       2,5-cyclohexadienone. The dienone portion is further reduced to
CC       cyclohexanone by the flavin-dependent reductase FrzD. The
CC       methyltranserases (MTs) FrzE and FrzF are then involved in the
CC       methylation at the C10' amine and the C4 phenolic oxygen, respectively.
CC       The order of the two MTs appear to be interchangeable. Cleavage of the
CC       C9-N10' bond by the dioxygenase FrzG then leads to formation of a
CC       conjugated iminium. In addition to the oxidation of C9, an additional
CC       dehydrogenation between C7 and C8 can occur to give a likely shunt
CC       product. The next biosynthetic step is the intramolecular aldol
CC       condensation catalyzed by the newly identified aldolase FrzH to yield
CC       an aza-tricyclic product with the formation of a C9-C3' bond
CC       (PubMed:33372776). The short-chain dehydrogenase/reductase FrzI then
CC       produces dephospho-(-)-FR901483 that is phosphorylated at C4'-OH into
CC       (-)-FR901483 by the phosphotransferase FrzJ (PubMed:33372776). The only
CC       unassigned enzyme in the cluster is the second cytochrome P450
CC       monooxygenase FrzL (PubMed:33372776). {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `fd48d108f45a92963462c2f0a750dcecfac5cc36c43941b4ca5d31b971333839`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M9?format=txt&versions=11)  
**Locator:** `lines 56-65`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-01T06:27:35.126419+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexane]-2',5'-dien-4'-one +
CC         2 NADPH + 2 H(+) = (1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + 2 NADP(+);
CC         Xref=Rhea:RHEA:83583, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:233174, ChEBI:CHEBI:233175;
CC         Evidence={ECO:0000269|PubMed:33372776};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:83584;
CC         Evidence={ECO:0000269|PubMed:33372776};
```

Source SHA-256: `fd48d108f45a92963462c2f0a750dcecfac5cc36c43941b4ca5d31b971333839`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M9?format=txt&versions=11)  
**Locator:** `lines 80-80`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-01T06:27:35.126419+00:00.  

```text
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
```

Source SHA-256: `fd48d108f45a92963462c2f0a750dcecfac5cc36c43941b4ca5d31b971333839`.

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 103623-103631`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0010181
name: FMN binding
namespace: molecular_function
def: "Binding to flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes." [GOC:tb]
synonym: "flavin mononucleotide binding" EXACT []
is_a: GO:0032553 ! ribonucleotide binding
is_a: GO:0043168 ! anion binding

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 69. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
